CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BIOSTAT-CHF aims to improve heart failure treatment by identifying patients at risk of poor outcomes despite standard therapies. The project utilizes genomic and proteomic data to develop a risk prediction model for personalized medicine.
Heart failure is common in Europe and its prevalence is increasing as our population ages.
Despite major improvements in care since the early 90s, it is still related to a poor prognosis, an impaired quality of life and high health care costs.
Many new therapies have failed to improve outcome further.
One obvious reason is that the response to treatment is not homogenous.
Treatment may need to be tailored to the individual patient. BIOSTAT-CHF aims to identify patients with a poor outcome, despi…
UNIVERSITAIR MEDISCH CENTRUM GRONINGEN
ACADEMISCH ZIEKENHUIS GRONINGEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Brescia
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Greece, Athina
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Hull
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
